Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has negatively impacted
on patients of the whole CKD spectrum, causing high rates of morbi-mortality. SARS-CoV-2 …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19), which has killed~ 7 million persons worldwide. Chronic kidney …

Introduction Hemodialysis (HD) patients are a COVID-19 high risk population due to
comorbidities and impaired immune response. Vaccines, advent of effective treatment and …

Introduction. Patients on peritoneal dialysis (PD) present an impaired humoral response
against SARS-CoV-2, at least after the initial vaccination and booster dose. Until now, the …

(1) Background: The impact of SARS-CoV-2 has been variable over the time course of the
pandemic and in different populations. The aim was to analyze the impact of COVID-19 …

After the COVID-19 pandemic, the Omicron variant of the SARS-CoV-2 virus became the
dominant lineage in Spain in 2022. Although it possesses a milder pathogenicity than …

Introduction: Despite the efficacy of the COVID-19, the search for improvements in the
management of severe/critical cases continues to be important. The aim is to demonstrate …

Tras la pandemia de la COVID-19, la variante ómicron del virus SARS-CoV-2 se convirtió en
el linaje dominante en España en 2022. Aunque posee una patogenicidad más leve que las …

La pandemia por SARS-CoV-2 ha evolucionado a lo largo de los 2 últimos años tanto por la
aparición de nuevas variantes como por el desarrollo y administración de la vacunación. La …

COVID-19 has proven to be particularly aggressive in patients with chronic kidney disease
(CKD). The lower immune response rate and the greater susceptibility to progress to severe …